A phase I/II dendritic cell (DC) immunotherapy trial for hepatocellular carcinoma (HC)

A phase I/II dendritic cell (DC) immunotherapy trial for hepatocellular carcinoma (HC)

Bibliographic Details
Main Authors:	Midgley, R, Kerr, D, Mirza, N, Palmer, D, Adams, D, Young, L
Format:	Journal article
Published:	2002

Similar Items

A Phase II trial of dendritic cell (DC) immunotherapy for hepatocellular carcinoma
by: Midgley, R, et al.
Published: (2004)

A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma.
by: Palmer, D, et al.
Published: (2009)

Dendritic cell vaccination for hepatocellular carcinoma.
by: Midgley, R, et al.
Published: (2003)

Comparison of monocyte versus CD34+precursors for the generation of clinical grade dendritic cells for immunotherapy protocols in hepatocellular carcinoma
by: Daniels, H, et al.
Published: (2005)

Activation of human dendritic cells for immunotherapy in ovarian carcinoma
by: Brencicova, E, et al.
Published: (2012)

Immunotherapy for colorectal cancer: a challenge to clinical trial design.
by: Midgley, R, et al.
Published: (2000)

Specific CD8+ T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis
by: Moreno-Cubero, E, et al.
Published: (2016)

Identification of an oligopeptide binding to hepatocellular carcinoma.
by: Shimizu, A, et al.
Published: (2006)

Immunotherapy for colorectal cancer.
by: Midgley, R, et al.
Published: (2003)

Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinoma
by: Chuah, Samuel, et al.
Published: (2022)

Immunotherapy for colorectal cancer: potential application in an adjuvant setting.
by: Kerr, D, et al.
Published: (2000)

Immunotherapy for colorectal cancer: Potential application in an adjuvant setting
by: Kerr, D, et al.
Published: (2000)

Primary Hepatocellular carcinoma: management and prognosis
by: Murtaza Mustafa, et al.
Published: (2016)

Histopathological landmarks of hepatocellular carcinoma in Malaysians
by: Cheah, P.L., et al.
Published: (2003)

Global epidemiology and genetics of hepatocellular carcinoma
by: Toh, Ming Ren, et al.
Published: (2023)

Expression of somatostatin receptors in hepatocellular carcinoma.
by: Tan, Hock Jin.
Published: (2011)

Novel treatments for hepatocellular cancer.
by: Kerr, S, et al.
Published: (2009)

Hepatocellular carcinoma with disseminated skeletal muscle metastasis
by: Abdul Rahim, Ezamin, et al.
Published: (2017)

Bile acids as drivers and biomarkers of hepatocellular carcinoma
by: Colosimo, S, et al.
Published: (2022)

Trajectory of immune evasion and cancer progression in hepatocellular carcinoma
by: Nguyen, Phuong H. D., et al.
Published: (2023)

Dendritic cell immunobiology and potential roles in immunotherapy
by: Fadilah, S.A.W., et al.
Published: (2007)

Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
by: Tse, R, et al.
Published: (2008)

Wnt Signaling Pathway Related Genes In Hepatocellular Carcinoma
by: Ban, Kechen
Published: (2002)

Human hepatocellular carcinoma diagnosis by multiphoton autofluorescence microscopy
by: So, Peter T. C., et al.
Published: (2010)

Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression
by: He, Michelle J., et al.
Published: (2022)

CTP synthase forms the cytoophidium in human hepatocellular carcinoma
by: Chang, C, et al.
Published: (2017)

T cells in HBV associated hepatocellular carcinoma and other cancers
by: Li, X
Published: (2017)

Prevention of hepatocellular carcinoma in the Asia-Pacific region: Consensus statements
by: Farrell, G.C., et al.
Published: (2010)

Fibrolamellar hepatocellular carcinoma complicating ulcerative colitis with primary sclerosing cholangitis.
by: Snook, J, et al.
Published: (1989)

Targeted inhibition of purine metabolism is effective in suppressing hepatocellular carcinoma progression
by: Chong, Yong Chun, et al.
Published: (2020)

Gastric Metastasis from Hepatocellular Carcinoma: A Rare Manifestation
by: Abdul Hakim, Mohamed Seenikatty, et al.
Published: (2018)

Mediastinal Hepatocellular Carcinoma with Unknown Primary: An Unusual and Rare Presentation
by: Koh, P.S., et al.
Published: (2014)

Tumour seeding following percutaneous needle biopsy of hepatocellular carcinoma
by: Qua, C.S., et al.
Published: (2008)

Unravelling genetic heterogeneity of hepatocellular carcinoma with driver genes and subclones
by: Ng, Ming Hwee
Published: (2015)

TACE and Continuous Intraarterial Infusion Chemotherapy in Advanced Hepatocellular Carcinoma
by: Perpustakaan UGM, i-lib
Published: (1993)

An evolutionary and genomic approach to understand tumor evolution in hepatocellular carcinoma
by: Kaya, Arife Neslihan
Published: (2021)

Therapeutic targeting of NAMPT and its associated pathways in hepatocellular carcinoma
by: Yeo, Joanna Zhen Zhen
Published: (2022)

Targeted polymeric therapeutic nanoparticles: Design and interactions with hepatocellular carcinoma
by: Wang, Qi, et al.
Published: (2016)

A phase 1 dose-finding and pharmacodynamic study of rapamycin in combination with bevacizumab in patients with unresectable hepatocellular carcinoma
by: Choo, S. P., et al.
Published: (2013)

NEIL1 protects against aflatoxin-induced hepatocellular carcinoma in mice
by: Vartanian, Vladimir, et al.
Published: (2018)